-
Published06/05/2025
-
Deadline05/06/2025
-
Opening of tenders05/06/2025
-
Awarded19/06/2025
-
Today24/06/2025
Utilities
- indicates CPV codes deduced from the text of the procedure
- indicates text translated automatically in your browsing language
Supplies of medicines - 120MG denosumab active substance for oncological indications - ATC M05BX04 Text automatically translated in your browsing language Automatically translated
The subject of the contract is the continuous supply of a medicinal product containing the active substance denosumab with a strength of 120MG intended for oncological indications – ATC M05BX04. LL – denosumab , pharmaceutical form 120MG INJ SOL ISP 1X1ML, unit of measurement 1X1ML/120MG, quantity 8 000 Text automatically translated in your browsing language Automatically translated
https://www.egordion.cz/nabidkaGORDION/profilTN
https://www.egordion.cz/nabidkaGORDION/profilTN
33632000 - Medicinal products for the musculo-skeletal system
33652000 - Antineoplastic and immunomodulating agents CVP code deduced from the text of the procedure AI-generated
33650000 - General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents CVP code deduced from the text of the procedure AI-generated
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.